iATROS is a technology company.
iATROS has raised $2.0M across 1 funding round.
iATROS has raised $2.0M in total across 1 funding round.
iATROS is a Munich-based digital health startup founded in 2019 that operates as a fully integrated digital heart clinic, delivering telemedicine solutions for patients with cardiovascular diseases like atrial fibrillation, high blood pressure, coronary heart disease, and heart failure.[1][2][3] Its mobile app enables data-driven care through smart sensor diagnostics (e.g., via smartwatches for blood pressure, heart rate, and pulse), AI-supported analysis for early anomaly detection, personalized therapy and medication plans, teledoctor consultations, sports/nutrition coaching, and automated reminders, serving both patients and clinics while partnering with health insurers to reach around 120,000 users and analyze over 10 million health values.[1][2][3][4] The company has raised $2.3M (€2M) in seed funding from High-Tech Gründerfonds, Bayern Kapital, and business angels, fueling staff expansion and platform growth, with early traction via clinic and insurer partnerships.[1][2][4]
iATROS was founded in 2019 by cardiologists Prof. Dr. med. Alexander Leber and Dr. med. Georges von Degenfeld, alongside eHealth entrepreneur Patrick Palacin, who recognized the need for location- and time-independent care to reduce uncertainties in managing cardiovascular conditions.[1][3] Co-founders include former Sky executive Prof. Wolfram Winter (communications expert) and ex-AOK Berlin finance director Jens Schäfer, bringing business and operational expertise.[1] The idea emerged from combining medical cardiology knowledge with telemedicine and digital health tech; a pivotal early moment was securing a €2M seed round in January 2020 from High-Tech Gründerfonds and Bayern Kapital, enabling rapid scaling of its app-based platform.[1][2][4]
iATROS rides the telehealth and digital therapeutics wave in Europe's aging population, where cardiovascular diseases affect millions, amplified by post-pandemic demand for remote monitoring and Germany's Digital Healthcare Act (DigiG) enabling prescription-reimbursed apps.[1][3] Timing aligns with regulatory progress—15 months post-DigiG, apps like iATROS gain reimbursement traction amid investor interest from funds like HTGF—while market forces like wearable tech proliferation (e.g., smartwatches) and AI advancements favor scalable, data-driven care over traditional clinic visits.[1][2][3] It influences the ecosystem by partnering with clinics, pharma, and insurers, accelerating DiGA adoption, reducing hospital burdens, and setting standards for AI-ethics in medtech, potentially expanding beyond Germany as cross-border telehealth evolves.[3][4]
iATROS is poised for expansion with its validated model, likely pursuing Series A funding to enhance AI diagnostics, integrate more wearables, and enter new markets amid rising DiGA approvals and global telecardiology demand.[1][3] Trends like AI personalization, insurer integrations, and preventive health will shape its path, evolving its influence from niche German player to broader European digital clinic leader, ultimately transforming reactive cardiology into proactive, patient-led care—building on its seed momentum to deliver scalable, life-improving impact.[2][3]
iATROS has raised $2.0M in total across 1 funding round.
iATROS's investors include Bayern Kapital.
iATROS has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in March 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2020 | $2.0M Seed | Bayern Kapital |